A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill ...

While House control is at the center of the midterms, which party holds the majority will be settled by a small share of the ...

A bipartisan group of senators is pushing to give the hemp industry two more years before a federal ban on THC products would ...

Clinician-scientists at the University of Pittsburgh School of Medicine have developed an artificial intelligence (AI) tool ...

If the Department of Justice finishes the process of rescheduling marijuana as recently directed by President Donald Trump, ...

Following the release of ChatGPT Health, due to an increased interest in AI-driven medical guidance, MNT discusses the role ...

The Missouri Attorney General’s Office renewed its attempts to access abortion patient records as it tries to make a case for ...

And then biotech does what biotech always does. It reminds you that in this corner of the market, the business is not the ...

Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.

The Federal Drug Administration’s current cybersecurity requirements are not appropriate for addressing and avoiding medical ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...